Decreased HbNO production in HbE/ß-thal subjects. by Attaphon Chamchoi (5774669)

Basal IKK activity is decreased in cells lacking IRE1. by Arvin B. Tam (124164)

Metabolites whose secretion or uptake is markedly decreased in AD. by Shiri Stempler (130579)

Table_1_Anti-Mitochondrial Antibody Titers Decrease Over Time in Primary Biliary Cholangitis Patients With Ursodeoxycholic Acid Therapeutic Response: A Cohort Study Followed Up to... by Ming-Ling Chang (44638)

“…Patients with baseline cirrhosis (2.78 ± 2.56 vs. 6.84 ± 9.00 mg/dL, p=0.024) and UDCA nonresponders (2.54 ± 2.19 vs. 4.51 ± 6.99 mg/dL, p=0.006) had increased total bilirubin levels while patients without cirrhosis (AST: 91.5 ± 84.5 vs. 58.9 ± 43.7 U/L, p<0.001; ALT: 107.3 ± 122.5 vs. 50.7 ± 36.8 U/L, p<0.001) and UDCA responders (AST: 83.8 ± 101.3 vs. 45.58 ± 38.42 U/L, p=0.014; ALT: 95.10 ± 144.6 vs. 39.12 ± 30.65 U/L, p=0.009) had decreased aminotransferase levels. …”

Image_1_Anti-Mitochondrial Antibody Titers Decrease Over Time in Primary Biliary Cholangitis Patients With Ursodeoxycholic Acid Therapeutic Response: A Cohort Study Followed Up to... by Ming-Ling Chang (44638)

“…Patients with baseline cirrhosis (2.78 ± 2.56 vs. 6.84 ± 9.00 mg/dL, p=0.024) and UDCA nonresponders (2.54 ± 2.19 vs. 4.51 ± 6.99 mg/dL, p=0.006) had increased total bilirubin levels while patients without cirrhosis (AST: 91.5 ± 84.5 vs. 58.9 ± 43.7 U/L, p<0.001; ALT: 107.3 ± 122.5 vs. 50.7 ± 36.8 U/L, p<0.001) and UDCA responders (AST: 83.8 ± 101.3 vs. 45.58 ± 38.42 U/L, p=0.014; ALT: 95.10 ± 144.6 vs. 39.12 ± 30.65 U/L, p=0.009) had decreased aminotransferase levels. …”

TNFα significantly decreases PRLR immunoreactivity in the outer root sheath of hair follicles. by Ewan A. Langan (405804)

“…(D) Negative control. (E) Quantitative analysis confirms decreased PRLR IR after TNFα treatment (13–17 HFs per group in total). …”

Changes in 50-kHz USV duration (A-D) and amplitude (E-H) in rats with 7 (ABEF) or 14 (CDGH) training days during training (ACEG) and test (BDFH) sessions. by Agnieszka D. Wardak (17941139)

<i>clec-4(ok2050)</i> and <i>clec-4(ya1)</i> decrease <i>C</i>. <i>elegans</i> feeding leading to a reduced bacterial load. by Barbara Pees (3313560)

SPARC overexpression promotes AC invasion by decreasing type IV collagen levels in the BM. by Meghan A. Morrissey (2541352)

The C-terminus of Ssa2 is required for HU resistance. by Laura E. Knighton (5991239)

D2D routing for relay node. by Bilal Ahmad (773365)

“…These nodes will use multi hop d2d relay approach to reach the energy centroid nodes. …”

BpiB09 affects the QS-dependent pyocyanin production, <i>C. elegans</i> paralysis in PAO1 and decreases AHL response in <i>A. tumefaciens</i> AHL reporter strain. by Patrick Bijtenhoorn (199146)

“…<p><b>A</b>) Decreased pyocyanin production. OD₅₂₀ of pyocyanin extracts from culture supernatants of <i>P. aeruginosa</i> carrying pBBR1MCS-5::<i>bpiB09</i> and empty pBBR1MCS-5. …”

The over-expression of dMi-2 does not decrease cohesin levels. by Barbara Fasulo (144611)

Decreased TRPV1 desensitization in TG sensory neurons exposed to tertiary low-level blast. by Elaine D. Por (546209)

Reduced RabGEF1 expression decreases NGF-induced TrkA phosphorylation but not TrkA internalization. by See-Ying Tam (828866)

Rescue of rpS6 phosphorylation deficient mice from myr-Akt1-induced insulinoma is associated with decreased cell proliferation and increased p27 nuclear localization. by Avigail Dreazen Wittenberg (2504134)

IL-15 treatment results in decreased lipid deposition in 3T3-L1 mature adipocytes and IL-6 and KC production with increasing IL-15 treatment. by Nicole G. Barra (317230)

Map of 91 federal, state, and local parks and protected area (PPA) study sites overlaid on Level 2 ecoregion. by Kira Minehart (21029571)

Characterization of anti-mDP2 MAbs. by Nanae Nagata (3916574)

Subjects:

Epitope mapping using swapped DP2 mutants. by Nanae Nagata (3916574)

Subjects: